Powl Brian T. — SEC insider filings

SEC reporting owner CIK 1934232. 17 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2022-06-29 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kura Oncology, Inc. (KURA)Chief Commercial Officer14—14 legs · 97,807 sh · $940,7019
FATE THERAPEUTICS INC (FATE)Chief Commercial Officer3—1 leg · 3,854 sh · $18,7693

Insider filings — Powl Brian T.

FiledFormIssuerReported transactionsSource
2026-11-194Kura Oncology, Inc. (KURA)Sale (S): 448 @ $7.27EDGAR
2026-11-184Kura Oncology, Inc. (KURA)Sale (S): 9,196 @ $7.44 · Sale (S): 15,254 @ $7.45EDGAR
2026-09-294Kura Oncology, Inc. (KURA)Sale (S): 9,020 @ $10.50 · Sale (S): 8,000 @ $10.56 · Sale (S): 15,430 @ $10.75EDGAR
2026-08-244Kura Oncology, Inc. (KURA)Sale (S): 4,345 @ $11.89EDGAR
2026-05-224Kura Oncology, Inc. (KURA)Sale (S): 10,000 @ $11EDGAR
2026-05-204Kura Oncology, Inc. (KURA)Sale (S): 339 @ $9.21EDGAR
2026-01-274Kura Oncology, Inc. (KURA)Sale (S): 4,842 @ $8.46 · Sale (S): 1,572 @ $8.46EDGAR
2026-01-064Kura Oncology, Inc. (KURA)Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-11-144Kura Oncology, Inc. (KURA)Grant/award (A): 48,900 @ $0 · Sale (S): 8,887 @ $11.18EDGAR
2025-09-294Kura Oncology, Inc. (KURA)Grant/award (A): 48,900 @ $0 · Sale (S): 8,891 @ $8.94EDGAR
2025-01-284Kura Oncology, Inc. (KURA)Sale (S): 1,583 @ $7.87EDGAR
2025-01-064Kura Oncology, Inc. (KURA)Grant/award (A): 46,250 @ $0 · Grant/award (A): 92,500 (derivative) @ $0EDGAR
2024-01-044Kura Oncology, Inc. (KURA)Grant/award (A): 15,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-08-164Kura Oncology, Inc. (KURA)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2023-07-064FATE THERAPEUTICS INC (FATE)Sale (S): 3,854 @ $4.87EDGAR
2023-02-074FATE THERAPEUTICS INC (FATE)Grant/award (A): 425,000 (derivative) @ $0EDGAR
2022-06-294FATE THERAPEUTICS INC (FATE)Grant/award (A): 45,000 @ $0 · Grant/award (A): 70,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1934232 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs